Why did GAAP earnings fall sharply in the fourth quarter while non-GAAP earnings rose?

GAAP diluted EPS was $4.20 versus $6.75 a year earlier. The decline reflects $52.5 million of pretax, non-cash trademark impairments, $49.7 million of acquired intangible amortization and smaller FLIR acquisition-related tax benefits ($16.6 million versus $102.2 million). Non-GAAP diluted EPS, which excludes these items, was $5.52 versus $5.44.

What is the company's 2025 earnings outlook?

Management expects full-year 2025 GAAP diluted EPS of $17.70 to $18.20 and non-GAAP diluted EPS of $21.10 to $21.50. For the first quarter of 2025, it expects GAAP diluted EPS of $3.90 to $4.04 and non-GAAP diluted EPS of $4.80 to $4.90. The outlook includes Micropac but excludes the pending Excelitas acquisition.

How strong was the company's cash generation and balance sheet in 2024?

Cash provided by operating activities was a record $1,191.9 million for the full year, and free cash flow was a record $1,108.2 million. Total debt was $2,649.0 million and net debt was $1,999.2 million at December 29, 2024. The quarter-end Consolidated Leverage Ratio was 1.5x, and $1.17 billion was available under the $1.20 billion credit facility.

What is changing on the Board of Directors?

Charles Crocker informed the Board on January 21, 2025, that he will retire as a director at the end of his term, which expires at the 2025 Annual Meeting of Stockholders, currently planned for April 23, 2025. The Board fixed the number of directors at 10 effective immediately before that meeting, with Class II directors reduced from four to three.

Which business segments drove results in the fourth quarter?

Instrumentation operating income rose to $100.8 million from $90.7 million, and Aerospace and Defense Electronics operating income rose to $56.4 million from $50.0 million. Digital Imaging operating income fell to $90.8 million from $134.3 million, mainly due to the $49.5 million trademark impairment. Engineered Systems operating income fell to $9.8 million from $12.3 million.

TDY 8-K: Earnings & Results & Leadership Changes

01—Abstract

Summary

Summary of the 8-K filed January 22, 2025. Cited figures are marked; the original filing is the authoritative source.

Teledyne Technologies Incorporated reported record fourth-quarter 2024 net sales of $1,502.3 million^a, up 5.4% from $1,425.0 million a year earlier, and record non-GAAP diluted earnings per share of $5.52.

GAAP diluted EPS fell to $4.20^b from $6.75, reflecting $52.5 million of non-cash trademark impairments, $49.7 million of acquired intangible amortization, and lower FLIR-related tax benefits ($16.6 million versus $102.2 million). For full year 2024, net sales were $5,670.0 million, up 0.6%, with GAAP diluted EPS of $17.21 (versus $18.49) and non-GAAP diluted EPS of $19.73. Record cash from operations of $1,191.9 million and free cash flow of $1,108.2 million supported $1.1 billion of capital deployment across debt repayment, share repurchases and acquisitions, with the quarter-end Consolidated Leverage Ratio at 1.5x.

The company guided to full-year 2025 GAAP diluted EPS of $17.70 to $18.20^c and non-GAAP diluted EPS of $21.10 to $21.50, with first-quarter 2025 GAAP EPS of $3.90 to $4.04 and non-GAAP EPS of $4.80 to $4.90. The outlook includes the recently completed Micropac acquisition but excludes the pending purchase of select aerospace and defense electronics businesses from Excelitas Technologies Corp. Management expects to deploy approximately $770 million on acquisitions in the first quarter of 2025. Management also cited a strong U.S. dollar and an unpredictable geopolitical environment as reasons for continued vigilance.

Segment results were mixed. Digital Imaging operating income fell to $90.8 million^d from $134.3 million, mainly due to the $49.5 million trademark impairment, while Instrumentation operating income rose 11.1% and Aerospace and Defense Electronics rose 12.8%.

Engineered Systems operating income declined 20.3%. The filing also reports that director Charles Crocker will retire at the end of his term at the 2025 Annual Meeting of Stockholders, and that the Board will reduce its size from 11 to 10 directors effective immediately before that meeting.

02—Key points

Key Highlights

Record Q4 2024 net sales of $1,502.3 million, up 5.4%; record Q4 non-GAAP diluted EPS of $5.52 versus $5.44, while GAAP diluted EPS was $4.20 versus $6.75.
Full-year 2024 net sales of $5,670.0 million, up 0.6%; GAAP diluted EPS of $17.21 versus $18.49 and non-GAAP diluted EPS of $19.73 versus $19.69.
Record full-year cash from operations of $1,191.9 million and free cash flow of $1,108.2 million; quarter-end Consolidated Leverage Ratio of 1.5x.
Net debt declined to $1,999.2 million at December 29, 2024, from $2,596.6 million at December 31, 2023.
2025 outlook: GAAP diluted EPS of $17.70 to $18.20 and non-GAAP diluted EPS of $21.10 to $21.50, including Micropac but excluding Excelitas.
Pending Excelitas aerospace and defense electronics acquisition; approximately $770 million of acquisition deployment expected in Q1 2025 after the Micropac acquisition closed December 30, 2024.
Q4 2024 included a $52.5 million non-cash trademark impairment, mostly in Digital Imaging, and Digital Imaging operating income fell to $90.8 million from $134.3 million.

03—Questions

Frequently Asked Questions

Why did GAAP earnings fall sharply in the fourth quarter while non-GAAP earnings rose?
GAAP diluted EPS was $4.20 versus $6.75 a year earlier. The decline reflects $52.5 million of pretax, non-cash trademark impairments, $49.7 million of acquired intangible amortization and smaller FLIR acquisition-related tax benefits ($16.6 million versus $102.2 million). Non-GAAP diluted EPS, which excludes these items, was $5.52 versus $5.44.
What is the company's 2025 earnings outlook?
Management expects full-year 2025 GAAP diluted EPS of $17.70 to $18.20 and non-GAAP diluted EPS of $21.10 to $21.50. For the first quarter of 2025, it expects GAAP diluted EPS of $3.90 to $4.04 and non-GAAP diluted EPS of $4.80 to $4.90. The outlook includes Micropac but excludes the pending Excelitas acquisition.
How strong was the company's cash generation and balance sheet in 2024?
Cash provided by operating activities was a record $1,191.9 million for the full year, and free cash flow was a record $1,108.2 million. Total debt was $2,649.0 million and net debt was $1,999.2 million at December 29, 2024. The quarter-end Consolidated Leverage Ratio was 1.5x, and $1.17 billion was available under the $1.20 billion credit facility.
What is changing on the Board of Directors?
Charles Crocker informed the Board on January 21, 2025, that he will retire as a director at the end of his term, which expires at the 2025 Annual Meeting of Stockholders, currently planned for April 23, 2025. The Board fixed the number of directors at 10 effective immediately before that meeting, with Class II directors reduced from four to three.
Which business segments drove results in the fourth quarter?
Instrumentation operating income rose to $100.8 million from $90.7 million, and Aerospace and Defense Electronics operating income rose to $56.4 million from $50.0 million. Digital Imaging operating income fell to $90.8 million from $134.3 million, mainly due to the $49.5 million trademark impairment. Engineered Systems operating income fell to $9.8 million from $12.3 million.

04—Continue

← View all 8-K filings